About Idenix

Idenix Pharmaceuticals, Inc., headquartered in Cambridge, MA, is a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral and other infectious diseases. Idenix's current focus is on the treatment of infections caused by hepatitis C virus (HCV) and human immunodeficiency virus (HIV).

The company believes that maintaining a full pipeline of drug candidates with the potential to become first- or best-in-class therapies for large and growing markets is critical to its long-term growth and success. Idenix seeks to optimize the value of new drug candidates through efficient, rapid and market-driven clinical development programs. Today, Idenix has a robust pipeline focused on agents that it believes will advance the treatment of hepatitis C and HIV.